As the President of Clearway Health, Nicole Faucher brings more than 20 years of broad healthcare leadership experience including direct patient care, healthcare IT and operations serving hospital and healthcare systems through strategic planning, financial performance & forecasting, operations, business development and growth.
Since joining Clearway Health in 2021, Faucher has overseen the strategy and maturation of the company, a provider of specialty pharmacy acceleration services for a diverse portfolio of hospitals and health systems. From rural and community-based hospitals to large academic, children’s and free-standing cancer facilities, the program helps to improve specialty medication access, patient outcomes, health equity and revenue potential so health systems can better serve vulnerable patients and families within their communities.
Faucher provides day-to-day leadership for Clearway Health’s executive team and is responsible for the company’s strategic plan, financial performance, technology delivery, operations, market expansion and client development.
A CPO in the C-suite determines how a health system can move from a cost center to a revenue center with healthy operating margins by investing in specialty pharmacy services that reduce burden for healthcare staff and improve care for patients.
Implementing a specialty pharmacy strategy and approach for growth not only creates a revenue stream for the system, but also establishes a high-touch patient engagement program that becomes a differentiator in the way service is delivered for their community.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.